Unresolved issues on the antenatal use of corticosteroids for fetal lung maturation
Antenatal corticosteroids (ACS) for fetal lung maturation is celebrating the 50th anniversary. The most recent Cochrane review concluded that there is robust evidence that a single course of ACS reduces the risk of perinatal death and respiratory distress syndrome. Some aspects of ACS remain unresol...
Saved in:
Main Authors: | Ioannis Tsakiridis (Author), Themistoklis Dagklis (Author), Cihat Şen (Author) |
---|---|
Format: | Book |
Published: |
Perinatal Medicine Foundation,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation
by: Themistoklis Dagklis, et al.
Published: (2022) -
The use of antenatal corticosteroids for fetal maturation in COVID-19: clinical practice statement by WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation
by: Themistoklis Dagklis, et al.
Published: (2022) -
Prophylactic antenatal corticosteroids for fetal lung maturity: Known unknowns and unknown unknowns
by: Laura Parnell, et al.
Published: (2020) -
Congenital Lung Malformations: Unresolved Issues and Unanswered Questions
by: Federica Annunziata, et al.
Published: (2019) -
Comparison of transabdominal and transvaginal ultrasonography for the assessment of cervical length in the third trimester of pregnancy
by: Ioannis Tsakiridis, et al.
Published: (2019)